The Rrad protein product, RAD-GTPase, is a well-characterized L-type calcium channel inhibitor,42,43 and its up-regulation has been described in human myocardial infarction under the control of the AP-1 family transcription factor ATF3. Here, ATF3 is linked to myocardial infarction.